Farms.com Home   News

CASE Construction Equipment delivers 125 units to Angola’s Ministry of Transport

CASE Construction Equipment, has recorded one of its largest deliveries for 2020 with an order for 125 units from the Angolan Ministry of Transport. Amidst the global COVID-19 pandemic, the construction sector has begun to see an uptake in activity as governments of countries with a downward trend in contagion enter into their respective next phases, reinstating select construction activities. This has been reflected within CNH Industrial N.V.’s (NYSE: CNHI / MI: CNHI) construction equipment business with recent deliveries to customers in Australia, China, Russia and Southeast Asia.
 
The latest signs of encouragement come from Africa, with this substantial delivery in Angola. The result of a tender won by Redondo y García SA, a key CASE partner in the country, the order consists of a mix of Backhoe Loaders, Crawler Excavators, Dozers and Graders. Aftermarket services tied to this delivery are being supported by local CASE dealer Ivecar SA. Despite the logistical slowdown related to COVID-19, the delivery has been successfully concluded.
 
Throughout the pandemic crisis, CNH Industrial has continued to support its global dealer network and to maintain aftermarket services. Today, the majority of CNH Industrial’s 67 global plants have reopened. To ensure the health and safety of its employees, the Company has established a global COVID-19 Safety Protocol throughout its plants and logistics centers, which encompasses 48 different measures and is in compliance with local regulations in all countries in which it operates.
Source : Case IH

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.